Shares of NovaBay Pharmaceuticals, Inc. (NYSEAMERICAN:NBY – Get Free Report) crossed above its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of $0.00 and traded as high as $0.57. NovaBay Pharmaceuticals shares last traded at $0.57, with a volume of 1,162,340 shares.
NovaBay Pharmaceuticals Stock Performance
The stock has a market capitalization of $2.40 million, a price-to-earnings ratio of -0.06 and a beta of 2.82.
NovaBay Pharmaceuticals Company Profile
NovaBay Pharmaceuticals, Inc develops and sells eyecare and wound care products in the United States and internationally. It offers Avenova Spray, a solution for removing foreign materials, including microorganisms and debris from skin around the eye, such as the eyelid; Avenova Eye Health Support antioxidant-rich oral supplements; Avenova Lubricating Eye Drops for instant relief; NovaWipes by Avenova; Avenova WarmEye Compress to soothe the eyes; and the i-Chek by Avenova to monitor physical eyelid health.
See Also
- Five stocks we like better than NovaBay Pharmaceuticals
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- Top 3 Investment Themes to Watch for in 2025
- What is the Nasdaq? Complete Overview with History
- Mega Buybacks in 2025: Why These 3 Leading Stocks Are Buys
- What is a Special Dividend?
- AMD vs. NVIDIA: The Better Semiconductor Bet for 2025
Receive News & Ratings for NovaBay Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NovaBay Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
